Alliance Global Partners lowered the firm’s price target on Tilray to $2.25 from $2.75 and keeps a Neutral rating on the shares. The firm is now applying a lower multiple to its estimates due to continued cannabis share losses in Canada and inconsistent cash flow generation, noting that it now models Q4 sales of $28.9M versus $26.5M prior, near the lower end of the implied guide, equating to an unchanged FY24 EBITDA forecast of $61M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Tilray Reported Earnings. Did it Beat Estimates?
- TLRY Earnings: Tilray Brands Plunges on Weak Guidance
- Tilray no longer expects to generate positive adjusted free cash flow for 2024
- Tilray reports Q3 adjusted EPS (0c), consensus (5c)
- Options Volatility and Implied Earnings Moves Today, April 09, 2024